⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

LQDA

Liquidia Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

69.12USD

+1.4400 (+2.13%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 69.12
P/E44.6
Dvd Ind Yld—
P/B31.71
P/S13.7
Curr EV/T12M EBITDA35.0
Mkt Cap (USD)6.2B
Curr EV (USD)6.0B
2)

Per Share Data

EPS T12M1.39
DPS—
Bk Val Per Sh2.19
Rev/Sh4.45
Cash/Sh3.18
Curr Shares Out89.5M
FCF/Sh1.49
3)

Cash Flow Analysis

P/CF36.9
Curr P/FCF41.1
CF/NI1.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales37.2%
Eff Interest Rate175.9%
4)

Growth Potential

Dil EPS 1Y Gr50.9%
Cap 1Y Gr-43.6%
BPS 1Y Gr-48.4%
R&D To Sales12.4%
Retention Rate100.0%
Rev 1Y Gr1031.2%
FCF 1Y Gr59.3%
Assets 1Y Gr42.4%
5)

Profitability

EBITDA0.2B
EBIT0.2B
Operating Margin37.4%
Pretax Margin13.0%
Net Margin30.7%
ROA35.6%
ROE131.8%
ROC63.8%
Asset Turnover1.16
6)

Structure

Current Ratio2.31
Quick Ratio2.08
Debt/Assets3.8%
Debt/Com Eq10.2%
Net Debt/EBITDA-1.55
Tot Debt/Capital9.2%
Gross Margin1.8%
EBIT/Int Exp6.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.